Unknown

Dataset Information

A Systematic Literature Review of Economic Evaluations of Antibiotic Treatments for Clostridium difficile Infection.


ABSTRACT:

Background and objective

Clostridium difficile infection (CDI) is associated with high management costs, particularly in recurrent cases. Fidaxomicin treatment results in lower recurrence rates than vancomycin and metronidazole, but has higher acquisition costs in Europe and the USA. This systematic literature review summarises economic evaluations (EEs) of fidaxomicin, vancomycin and metronidazole for treatment of CDI.

Methods

Electronic databases (MEDLINE®, Embase, Cochrane Library) and conference proceedings (ISPOR, ECCMID, ICAAC and IDWeek) were searched for publications reporting EEs of fidaxomicin, vancomycin and/or metronidazole in the treatment of CDI. Reference bibliographies of identified manuscripts were also reviewed. Cost-effectiveness was evaluated a

SUBMITTER: Burton HE 

PROVIDER: S-EPMC5656734 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature